Across TCGA pan-cancer cohorts, FAM241A mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated FAM241A data layer compared with 26 for mass-spec protein and 2 for mutation status.
The strongest signal is observed in lung squamous cell carcinoma (LSCC), where higher FAM241A mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated FAM241A expression acts as an unfavorable survival marker, although some lineages such as LUAD and HNSC show a favorable association.
LSCC, LUAD, and HNSC are the cancer types where FAM241A mass-spec protein most reproducibly stratifies survival.